Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 1

Interventions

eltrombopag 7romiplostim 6Cytarabine 3Carboplatin 3Platelet Transfusion 2Cyclophosphamide 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2sodium thiosulfate 1pegfilgrastim 1oprelvekin 1ofatumumab 1lusutrombopag 1fludarabine 1etoposide phosphate 1avatrombopag 1angiotensin I (1-7) 1Tranexamic Acid 1Stem Cell Transplantation 1Sirolimus 1Saline Solution 1Rituximab 1Microarray Analysis 1Lenalidomide 1Interleukin-11 1Ifosfamide 1Hematopoietic Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Gene Expression Profiling 1Gemcitabine 1Flow Cytometry 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Thrombocytopenia × avatrombopag × Clear all
NCT03471078 2023-09-28

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

Sobi, Inc.

Phase 3 Completed
122 enrolled 19 charts
Classical hematology

Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡